Breaking News

Eurofins Launches Biologics Initiative for mAbs and Therapeutic Proteins

Includes analytical, upstream and downstream development, process design, gap analysis, scale up, bioassays and cGMP quality documentation.

Eurofins CDMO Alphora Inc. launched its Biologics initiative as part of its vision to diversify and grow within the contract development and manufacturing industry in North America. The multiphase initiative aims to establish a facility at the 2070 Hadwen site within the Sheridan Research Park campus in Mississauga, ON, Canada. The first phase of the project, scheduled for completion by December 2023, is a 3,300 square foot pilot scale facility focused on mammalian cell culture (mAbs) and the...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters